Is Ingredion Incorporated (INGR) Undervalued? Valuation & Fair Price
At $96.72, 3 of the 4 frameworks would buy Ingredion Incorporated today — Warren Buffett, Benjamin Graham, and Peter Lynch rate it Buy and Phil Town (Rule #1) rates it Avoid. Each model calculates its own fair value and margin of safety; create a free account to see the exact buy price behind every verdict.
Ingredion Incorporated
INGRConsumer Defensive · Packaged Foods · NYSE
$96.72
P/E 11.2×
Ingredion Incorporated, along with its affiliated entities, specializes in the global production and sale of starches and sweeteners, catering to a diverse range of industries. The company's operations are strategically organized into four geographical segments: North America, South America, Asia-Pacific, and Europe, the Middle East, and Africa. Its extensive product portfolio includes a variety of sweetener solutions such as glucose, high maltose, and high fructose corn syrups, as well as caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids. Beyond sweeteners, Ingredion also provides food-grade and industrial starches, biomaterials, and key nutrition ingredients. The company further offers specific corn-derived products like edible corn oil, and refined corn oil supplied to manufacturers of cooking oils, margarine, salad dressings, shortening, and mayonnaise. It also produces corn gluten feed, a protein source for poultry, pet food, and aquaculture. Additionally, Ingredion processes fruit and vegetable products, delivering concentrates, purees, essences, pulse proteins, and hydrocolloid systems and blends. These ingredients are predominantly extracted from corn, alongside other starch-rich raw materials such as tapioca, potatoes, and rice. Ingredion's primary clientele hails from the food, beverage, brewing, and animal nutrition sectors. Established in 1906, the firm was initially known as Corn Products International, Inc., before officially rebranding to Ingredion Incorporated in June 2012. Its corporate headquarters are situated in Westchester, Illinois.
Investor scorecard
How the four investors rate Ingredion Incorporated
3 of 4 frameworks lean Buy
Investor model analysis
Details lockedAt $96.72, 3 of 4 frameworks say Buy
Intrinsic Value (DCF)
Warren Buffett's valuation model · select an investor above to switch
Intrinsic Value
Locked — upgrade to viewBuy Below
Locked — upgrade to viewStrong Buy
Locked — upgrade to viewMargin of Safety
Locked — upgrade to viewUnlock buy targets with a free account
Get startedCreate a free account to see buy targets, full checklists & risk analysis Get started
Insider & congress activity
Are insiders buying INGR?
Over recent SEC Form 4 filings, INGR insiders bought $0 and sold $1.5M of stock across 5 open-market trades. Insiders sell for many reasons, but they buy for one.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Fischer David Bdirector | Sell | 1,662 | $170K | Aug 5, 2026 |
| Uribe Jorge A.director | Sell | 1 | $83 | Mar 31, 2026 |
| Gable Davida MarieVP Corp. Controller, Finance | Sell | 375 | $42K | Mar 18, 2026 |
| Zallie James P.President and CEO | Sell | 9,958 | $1.2M | Feb 18, 2026 |
| Fernandes LarrySVP, Chief Comm & Sust Officer | Sell | 1,125 | $131K | Feb 18, 2026 |
Members of Congress have also reported 5 trades in INGR. See the full insider & congress timeline.
Source: SEC Form 4 filings. Open-market buys & sells only. Not investment advice.
See the interactive insider chart & every tradeScenario analysis
Bear, base & bull
Three growth assumptions, three fair values — and where today's price lands
What's working
Key strengths
Identified by Buffett framework analysis
Company financials
5-Year Financials
Income statement highlights — annual, USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $7.2B | $7.4B | $8.2B | $7.9B | $6.9B |
| Rev. Growth | -2.8% | -8.9% | +2.7% | +15.3% | — |
| Net Income | $729M | $647M | $643M | $492M | $117M |
| Net Margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% |
| EPS (Diluted) | $11.36 | $9.88 | $9.74 | $7.43 | $1.74 |
| Free Cash Flow | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view |
Full analysis included
See the complete picture for INGR
Exact buy targets, margin of safety, detailed investor checklists, and risk breakdown — all frameworks, all numbers.
Free: 3 analyses/month · Pay per stock: $4.99 · Pro: $19.99/mo
More Consumer Defensive stocks
Educational Use Only · Not Financial Advice
Analysis, scores, valuations, and buy zones are derived from publicly documented investor frameworks (Buffett, Lynch, Benjamin Graham, Phil Town) for learning purposes only. They are not recommendations from licensed financial advisors. Past performance does not guarantee future results. Prices may be delayed up to 15 minutes. Always conduct your own research before making any investment decisions.